Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance

(2020) Satish R. Raj et al.   CANADIAN JOURNAL OF CARDIOLOGY

Neurological manifestations of COVID-19, SARS and MERS

(2020) Kato Verstrepen et al.   ACTA NEUROLOGICA BELGICA

A case report of postural tachycardia syndrome after COVID-19

(2020) Mitchell G. Miglis et al.   CLINICAL AUTONOMIC RESEARCH

Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies

(2020) Melanie Dani et al.   CLINICAL MEDICINE

Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G‐Protein Coupled Receptor Autoantibodies

(2019) William T. Gunning et al.   Journal of the American Heart Association

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome

(2018) Xichun Yu et al.   Journal of the American Heart Association

Autoimmune postural orthostatic tachycardia syndrome

(2018) Mari Watari et al.   Annals of Clinical and Translational Neurology

Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management

(2018) A. Fedorowski   JOURNAL OF INTERNAL MEDICINE

Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS)

(2015) S Blitshteyn   LUPUS

Autoimmune Basis for Postural Tachycardia Syndrome

(2014) Hongliang Li et al.   Journal of the American Heart Association

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

(2011) Roy Freeman et al.   CLINICAL AUTONOMIC RESEARCH